Given the experience of other drugs that affect the primobolan depot side effects, it should be used with caution in aliskiren with potassium salts, potassium-sparing diuretics, potassium-containing salt substitutes for food or any other drugs, being able to increase the concentration of potassium in the blood.
In patients with diabetes in the background aliskiren therapy in combination with an ACE inhibitor was an increase in the frequency of hyperkalemia (5.5%). When applying Rasileza and other drugs affecting RAAS in patients suffering from diabetes must regularly monitor plasma electrolytes and kidney function.
The drug should be discontinued primobolan depot side effects immediately if signs of an allergic reaction (eg, difficulty with breathing or swallowing, swelling of the face, extremities, lips, tongue). The therapy Rasilezom may increase the concentration of potassium, creatinine, blood urea nitrogen, typical of drugs affecting RAAS.
Early treatment Rasilezom in patients with a reduced volume of circulating blood (CBV) and / or hyponatremia (including due to high doses of diuretics), symptomatic hypotension is possible. Before using the product should carry out the correction of violations of water-salt balance. In patients with reduced BCC and / or hyponatremia treatment should be under close medical supervision.
Effects on ability to drive vehicles and use machines
The effect of primobolan depot side effects on the ability to drive vehicles and operate machinery has not been studied.